Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Chinese Journal of Cancer ; (12): 317-320, 2010.
Artigo em Inglês | WPRIM (Pacífico Ocidental) | ID: wpr-292588

RESUMO

<p><b>BACKGROUND AND OBJECTIVE</b>It has been proven that Ezrin protein may interact with E-cadherin protein and take part in metastasis of tumor cells. This study was to investigate the expressions of Ezrin and E-cadherin in esophageal squamous cell carcinoma (ESCC) and their relationship with the clinicopathologic factors, and analyze their diagnostic values for ESCC.</p><p><b>METHODS</b>The expression of Ezrin and E-cadherin in 72 specimen of ESCC and the paracancer normal squamous epithelium was detected using tissue array with SP immunohistochemistry. Their correlations to the clinicopathologic factors were analyzed statistically.</p><p><b>RESULTS</b>The positive rate of Ezrin was significantly higher in ESCC than in para-cancer normal squamous epithelium (90.7% vs. 46.0%, P < 0.001); the positive rate of E-cadherin was significantly lower in ESCC than in para-cancer normal squamous epithelium (27.6% vs. 97.4%, P < 0.001). Ezrin expression was related to the invasiveness and lymph node metastasis of ESCC (P < 0.05); E-cadherin expression was related to the differentiation and lymph node metastasis of ESCC (P < 0.05). The high expression of Ezrin was related to the low expression of E-cadherin (P < 0.05).</p><p><b>CONCLUSION</b>The activation of Ezrin and the absence of E-cadherin contribute to the tumorigenesis and metastasis of ESCC.</p>


Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Caderinas , Metabolismo , Carcinoma de Células Escamosas , Metabolismo , Patologia , Diferenciação Celular , Proteínas do Citoesqueleto , Metabolismo , Neoplasias Esofágicas , Metabolismo , Patologia , Metástase Linfática , Invasividade Neoplásica
2.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-334063

RESUMO

The aim of this study was to clarify whether bortezomib might induce apoptosis in Burkitt's lymphoma Raji cell line and its mechanism. Different concentrations of bortezomib were used to treat Raji cells and its effects of time and dose were observed. Cell morphology was observed under light microscope; flow cytometry was used to analyze cell apoptosis; RT-PCR was used to detect the expressions of NF-kappaB and p53 gene mRNAs. The results showed that the bortezomib could inhibit Raji cell growth within a certain range of treating time and dose. Apoptosis were induced in relation to time and dose. The expression of NF-kappaB mRNA and p53 mRNA decreased after treatment with bortezomib. It is concluded that the bortezomib can induce Raji cell apoptosis, which provides a theoretical basis for clinical treatment. NF-kappaB and p53 gene are supposed to participate in the bortezomib induced apoptosis of Raji cells.


Assuntos
Humanos , Apoptose , Ácidos Borônicos , Farmacologia , Bortezomib , Linfoma de Burkitt , Metabolismo , Patologia , Linhagem Celular Tumoral , Proliferação de Células , Citometria de Fluxo , NF-kappa B , Metabolismo , Pirazinas , Farmacologia , Proteína Supressora de Tumor p53 , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...